Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Buy
54
ELUT Quote, Financials, Valuation and Earnings
Last price:
$4.32
Seasonality move
:
20.77%
Day range:
$4.31 - $4.48
52-week range:
$1.97 - $5.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.69x
P/B ratio:
--
Volume:
36.5K
Avg. volume:
44K
1-year change:
111.76%
Market cap:
$149.3M
Revenue:
$24.7M
EPS (TTM):
-$2.62
Analysts' Opinion
-
Consensus RatingElutia has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.00, Elutia has an estimated upside of 108.33% from its current price of $4.32.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $10.00 representing 100% downside risk from its current price of $4.32.
Fair Value
-
According to the consensus of 2 analysts, Elutia has 108.33% upside to fair value with a price target of $10.00 per share.
ELUT vs. S&P 500
-
Over the past 5 trading days, Elutia has underperformed the S&P 500 by -0.09% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Elutia does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Elutia revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Elutia reported revenues of $5.9M.
Earnings Growth
-
Elutia has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Elutia reported earnings per share of -$0.33.
Enterprise value:
146.2M
EV / Invested capital:
-8.31x
Price / LTM sales:
4.69x
EV / EBIT:
--
EV / Revenue:
5.90x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
-7.29x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$10.5M
Return On Assets:
-121.16%
Net Income Margin (TTM):
-218.72%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
-93.67%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $40.8M | $25.5M | $24.8M | $6.1M | $5.9M | |
| Gross Profit | $15.5M | $12M | $10.5M | $2.8M | $2.7M | |
| Operating Income | -$29.9M | -$21M | -$24.3M | -$3.3M | -$5.5M | |
| EBITDA | -$28.9M | -$22.5M | -$51.6M | -$6.1M | $3.3M | |
| Diluted EPS | -$2.84 | -$2.10 | -$2.62 | -$0.57 | -$0.33 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $22.2M | $39.3M | $43.7M | $39.1M | $37.3M | |
| Total Assets | $46.1M | $59.9M | $61M | $54.6M | $48.4M | |
| Current Liabilities | $25.6M | $22.5M | $40.2M | $44.7M | $39.7M | |
| Total Liabilities | $121M | $52M | $71.7M | $84.1M | $88.6M | |
| Total Equity | -$74.9M | $7.9M | -$10.7M | -$29.5M | -$40.2M | |
| Total Debt | $30M | $22.1M | $20M | $25.3M | $22.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$22.6M | -$17.9M | -$19.5M | -$5.1M | -$3.4M | |
| Cash From Investing | -$431K | -$463K | $14.2M | -$62K | -$547K | |
| Cash From Financing | $8.5M | $24.8M | $16.6M | $10.4M | $11.5M | |
| Free Cash Flow | -$23M | -$18.4M | -$20.1M | -$5.2M | -$4M | |
ELUT
Sector
Market Cap
$149.3M
$46.1M
Price % of 52-Week High
82.44%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
111.77%
-30.52%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$4.17
200-day SMA
Buy
Level
$3.64
Bollinger Bands (100)
Buy
Level
3.41 - 4.27
Chaikin Money Flow
Sell
Level
-1.8M
20-day SMA
Buy
Level
$4.23
Relative Strength Index (RSI14)
Buy
Level
52.94
ADX Line
Buy
Level
13.62
Williams %R
Neutral
Level
-33.7662
50-day SMA
Buy
Level
$3.89
MACD (12, 26)
Buy
Level
0.07
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
25.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-7.7435)
Sell
CA Score
(Annual)
Level (-7.2174)
Buy
Beneish M-Score
(Annual)
Level (-4.7564)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (13.1766)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women’s Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Stock Forecast FAQ
In the current month, ELUT has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ELUT average analyst price target in the past 3 months is $10.00.
-
Where Will Elutia Stock Be In 1 Year?
According to analysts, the consensus estimate is that Elutia share price will rise to $10.00 per share over the next 12 months.
-
What Do Analysts Say About Elutia?
Analysts are divided on their view about Elutia share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Elutia is a Sell and believe this share price will drop from its current level to $10.00.
-
What Is Elutia's Price Target?
The price target for Elutia over the next 1-year time period is forecast to be $10.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ELUT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Elutia is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ELUT?
You can purchase shares of Elutia via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Elutia shares.
-
What Is The Elutia Share Price Today?
Elutia was last trading at $4.32 per share. This represents the most recent stock quote for Elutia. Yesterday, Elutia closed at $4.32 per share.
-
How To Buy Elutia Stock Online?
In order to purchase Elutia stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
